US Patent 11014909 Heteroaromatic compounds and their use as dopamine D1 ligands

Patent 11014909 was granted and assigned to Pfizer Limited on May, 2021 by the United States Patent and Trademark Office.

Is a

Patent Applicant

Current Assignee

Patent Jurisdiction

Patent Number

Date of Patent

May 25, 2021

Patent Application Number

16880632

Date Filed

May 21, 2020

Patent Citations

Patent Primary Examiner

Patent abstract

The present invention provides, in part, compounds of Formula I:

No Timeline data yet.

Title

Author

Link

Type

Date

No Further Resources data yet.

Find more entities like US Patent 11014909 Heteroaromatic compounds and their use as dopamine D1 ligands

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.